Q3 Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Q3 Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-34,918	Closed	-$5.8M	–	47
2021 Q3	$5.8M	Buy	+34,918	New	+$5.96M	2.8%	7
2020 Q3	–	Sell	-26,961	Closed	-$4.55M	–	29
2020 Q2	$4.55M	Buy	26,961 +18,613	+223%	+$2.92M	4.35%	8
2020 Q1	$1.12M	Buy	8,348 +1,604	+24%	+$229K	1.15%	17
2019 Q4	$1M	Buy	+6,744	New	+$926K	2.26%	13

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Q3 Asset Management's FBT Position: Q4 2021 in Review

Q3 Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2021, closing a stake of 34,918 shares — an estimated $5.8M sold.

Q3 Asset Management first reported a position in FBT in Q4 2019 and held it in 4 quarters. The position peaked at $5.8M in Q3 2021. 247 funds tracked by Wall St. Rank hold FBT as of Q4 2021.

Q3 Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2021 after selling out during the quarter.
Q3 Asset Management sold 34,918 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2021, an estimated $5.8M.
Q3 Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 4 quarters.
Q3 Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $5.8M in Q3 2021.
247 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2021.

Based on Q3 Asset Management's 13F filing for Q4 2021, filed 25 Jan 2022.